Article
[Impact of molecular targeting therapy on tumor immunity].
Nihon rinsho. Japanese journal of clinical medicine - 1 Aug 2015
Jinushi Masahisa, Akita Hirotoshi
Abstract excerpt
Emerging evidence has been unveiled that major oncogenic pathways, which serve as a main focus for the molecular targeting therapies, play a pivotal role in establishing immunosuppressive tumor microenvironments. The modulation of various immune modulatory pathways, such as upregulation of PD-L1 by various oncogenic mutations such as EGFR, BRAF, activation of PI3K and JAK-Stat3 on tumor cells, may be critical in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
